Tumor Ablation Market Size Forecasted To Achieve $2.54 Billion By 2029 With Steady Growth

The Tumor Ablation Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Tumor Ablation Market Size and Projected Growth Rate?
The tumor ablation market will grow from $1.45 billion in 2024 to $1.62 billion in 2025, with a CAGR of 12.1%. The growth in recent years has been due to the development of more efficient and precise ablation techniques, increasing healTH*Care expenditure in emerging economies, the aging population, the growing burden of cancer, and the rising global prevalence of cancer.

The tumor ablation market is forecasted to grow to $2.54 billion by 2029 with a CAGR of 11.8%. This growth is driven by the increasing incidence of cancer, the popularity of minimally invasive procedures, and growing healTH*Care cost-effectiveness. Major trends include technological advancements, integration of AI, and a shift toward patient-centric and outpatient approaches.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17283

What Are the Major Segments in the Tumor Ablation Market?
The tumor ablation market covered in this report is segmented -

1) By Type: Thermal Ablation, Chemical Ablation
2) By Types Of Treatment: Percutaneous, Laparoscopic, Surgical
3) By Application: Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Cancer
4) By End Users: Hospitals, Oncology Centers, Other End Users

Subsegments:
1) By Thermal Ablation: Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Cryoablation, Laser Ablation, High-Intensity Focused Ultrasound (HIFU)
2) By Chemical Ablation: Ethanol Ablation, Acetic Acid Ablation, Chemotherapy-Based Ablation (Chemoembolization)

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=17283&type=smp

What Are The Driving Tumor Ablation Market Evolution?
The increasing use of minimally invasive procedures is expected to drive the growth of the tumor ablation market. Minimally invasive procedures, which involve small incisions or no incisions, are gaining popularity due to their lower recovery times and fewer complications compared to traditional surgeries. Tumor ablation, a form of treatment used in minimally invasive procedures, helps destroy cancerous tissue with minimal damage to surrounding healthy tissues. For example, in January 2024, Intuitive Surgical Inc. reported a 12% increase in the placement of their da Vinci robotic systems used in minimally invasive surgeries, reflecting the growing trend of such procedures in the tumor ablation market.

Which Firms Dominate The Tumor Ablation Market Segments?
Major companies operating in the tumor ablation market are Abbott Laboratories, Medtronic plc, Siemens Healthineers AG, Stryker Corporation, Boston Scientific Corporation, Olympus Corporation, Terumo Corporation, Varian Medical Systems Inc., Merit Medical Systems Inc., Bioventus LLC, Accuray Incorporated, AtriCure Inc., AngioDynamics Inc., EDAP TMS S.A., NeuWave Medical Inc., Mirabilis Medical Inc., STARMed Co. Ltd., Profound Medical Corp., RF Medical Co. Ltd., IceCure Medical Ltd., MedWaves Inc., Chongqing Haifu Medical Technology Co. Ltd.

What Trends Are Expected to Dominate the Tumor Ablation Market in the Next 5 Years?
Companies in the tumor ablation market are creating innovative products like bone tumor ablation systems to improve treatment outcomes and expand the range of tumors that can be treated. These systems are designed for minimally invasive procedures. For example, in March 2024, Medtronic plc, an Ireland-based medical device company, received FDA clearance for the OsteoCool 2.0 bone tumor ablation system. This upgraded system allows for the simultaneous use of four internally cooled probes, enabling larger ablation zones and more efficient treatment of bone tumors, including metastases and benign tumors.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/tumor-ablation-global-market-report

Which Is The Largest Region In The Tumor Ablation Market?
North America was the largest region in the tumor ablation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the tumor ablation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Tumor Ablation Market?
2. What is the CAGR expected in the Tumor Ablation Market?
3. What Are the Key Innovations Transforming the Tumor Ablation Industry?
4. Which Region Is Leading the Tumor Ablation Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.